{"id":"https://openalex.org/W4399376830","doi":"https://doi.org/10.1016/j.intimp.2024.112383","title":"Discovery and preclinical evaluation of KYS202004A, a novel bispecific fusion protein targeting TNF-\u03b1 and IL-17A, in autoimmune disease models","display_name":"Discovery and preclinical evaluation of KYS202004A, a novel bispecific fusion protein targeting TNF-\u03b1 and IL-17A, in autoimmune disease models","publication_year":2024,"publication_date":"2024-06-05","ids":{"openalex":"https://openalex.org/W4399376830","doi":"https://doi.org/10.1016/j.intimp.2024.112383","pmid":"https://pubmed.ncbi.nlm.nih.gov/38843642"},"language":"en","primary_location":{"id":"doi:10.1016/j.intimp.2024.112383","doi":"https://doi.org/10.1016/j.intimp.2024.112383","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.intimp.2024.112383","pdf_url":null,"source":{"id":"https://openalex.org/S158377717","display_name":"International Immunopharmacology","issn_l":"1567-5769","issn":["1567-5769","1878-1705"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Immunopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101890300","display_name":"Zhihang Liu","orcid":"https://orcid.org/0009-0000-6281-418X","observed_orcids":["https://orcid.org/0009-0000-6281-418X"]},"institutions":[{"id":"https://openalex.org/I4210096033","display_name":"Kanion Pharmaceutical (China)","ror":"https://ror.org/00rn0n724","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096033"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhihang Liu","raw_affiliation_strings":["Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China","institution_ids":["https://openalex.org/I4210096033"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100967120","display_name":"Liying Song","orcid":"https://orcid.org/0000-0001-9605-9899","observed_orcids":["https://orcid.org/0000-0001-9605-9899"]},"institutions":[{"id":"https://openalex.org/I4210129127","display_name":"The First People\u2019s Hospital of Lianyungang","ror":"https://ror.org/03617rq47","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210129127"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Liying Song","raw_affiliation_strings":["Department of Oncology, The First People's Hospital of Lianyungang, No. 182, Tongguan Road, Lianyungang City 222002, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, The First People's Hospital of Lianyungang, No. 182, Tongguan Road, Lianyungang City 222002, Jiangsu Province, China","institution_ids":["https://openalex.org/I4210129127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000895400","display_name":"Jiarui Yang","orcid":"https://orcid.org/0000-0001-8238-7699","observed_orcids":["https://orcid.org/0000-0001-8238-7699","https://orcid.org/0009-0001-3099-2616","https://orcid.org/0009-0002-2619-3835"]},"institutions":[{"id":"https://openalex.org/I4210096033","display_name":"Kanion Pharmaceutical (China)","ror":"https://ror.org/00rn0n724","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096033"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jiarui Yang","raw_affiliation_strings":["Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China","institution_ids":["https://openalex.org/I4210096033"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113241168","display_name":"Han Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I191208505","display_name":"Xiamen University","ror":"https://ror.org/00mcjh785","country_code":"CN","type":"education","lineage":["https://openalex.org/I191208505"]},{"id":"https://openalex.org/I4405272336","display_name":"State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics","ror":"https://ror.org/040qz4226","country_code":"CN","type":"facility","lineage":["https://openalex.org/I4405272336"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Han Liu","raw_affiliation_strings":["State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen City 361102, Fujian Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen City 361102, Fujian Province, China","institution_ids":["https://openalex.org/I191208505","https://openalex.org/I4405272336"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yating Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096033","display_name":"Kanion Pharmaceutical (China)","ror":"https://ror.org/00rn0n724","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096033"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yating Zhang","raw_affiliation_strings":["Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China","institution_ids":["https://openalex.org/I4210096033"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048804577","display_name":"Xuelei Pi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096033","display_name":"Kanion Pharmaceutical (China)","ror":"https://ror.org/00rn0n724","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096033"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xuelei Pi","raw_affiliation_strings":["Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China","institution_ids":["https://openalex.org/I4210096033"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061514334","display_name":"Yuanyuan Yan","orcid":"https://orcid.org/0000-0001-9406-0896","observed_orcids":["https://orcid.org/0000-0001-9406-0896"]},"institutions":[{"id":"https://openalex.org/I4210096033","display_name":"Kanion Pharmaceutical (China)","ror":"https://ror.org/00rn0n724","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096033"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yuanyuan Yan","raw_affiliation_strings":["Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China","institution_ids":["https://openalex.org/I4210096033"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035855496","display_name":"Hongna Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096033","display_name":"Kanion Pharmaceutical (China)","ror":"https://ror.org/00rn0n724","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096033"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hongna Chen","raw_affiliation_strings":["Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China","institution_ids":["https://openalex.org/I4210096033"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113241169","display_name":"Dan Yu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096033","display_name":"Kanion Pharmaceutical (China)","ror":"https://ror.org/00rn0n724","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096033"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Dan Yu","raw_affiliation_strings":["Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China","institution_ids":["https://openalex.org/I4210096033"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048686695","display_name":"Chengkai Yin","orcid":"https://orcid.org/0009-0004-9726-4527","observed_orcids":["https://orcid.org/0009-0004-9726-4527"]},"institutions":[{"id":"https://openalex.org/I4210096033","display_name":"Kanion Pharmaceutical (China)","ror":"https://ror.org/00rn0n724","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096033"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chengkai Yin","raw_affiliation_strings":["Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China","institution_ids":["https://openalex.org/I4210096033"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113241167","display_name":"Tianyan Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096033","display_name":"Kanion Pharmaceutical (China)","ror":"https://ror.org/00rn0n724","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096033"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Tianyan Liu","raw_affiliation_strings":["Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China","institution_ids":["https://openalex.org/I4210096033"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112117745","display_name":"Xu Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096033","display_name":"Kanion Pharmaceutical (China)","ror":"https://ror.org/00rn0n724","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096033"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xu Li","raw_affiliation_strings":["Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China","institution_ids":["https://openalex.org/I4210096033"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102870001","display_name":"Chenfeng Zhang","orcid":"https://orcid.org/0000-0003-2886-2385","observed_orcids":["https://orcid.org/0000-0003-2886-2385"]},"institutions":[{"id":"https://openalex.org/I4210096033","display_name":"Kanion Pharmaceutical (China)","ror":"https://ror.org/00rn0n724","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096033"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chenfeng Zhang","raw_affiliation_strings":["Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China","institution_ids":["https://openalex.org/I4210096033"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101425130","display_name":"Deshan Li","orcid":"https://orcid.org/0000-0003-1859-5076","observed_orcids":["https://orcid.org/0000-0003-1859-5076"]},"institutions":[{"id":"https://openalex.org/I4210096033","display_name":"Kanion Pharmaceutical (China)","ror":"https://ror.org/00rn0n724","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096033"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Deshan Li","raw_affiliation_strings":["Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China","institution_ids":["https://openalex.org/I4210096033"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113341378","display_name":"Zhenzhong Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096033","display_name":"Kanion Pharmaceutical (China)","ror":"https://ror.org/00rn0n724","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096033"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Zhenzhong Wang","raw_affiliation_strings":["Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China. Electronic address: kyyywzz@163.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China. Electronic address: kyyywzz@163.com","institution_ids":["https://openalex.org/I4210096033"]}]},{"author_position":"last","author":{"id":null,"display_name":"Wei Xiao","orcid":"https://orcid.org/0000-0001-8809-9137","observed_orcids":["https://orcid.org/0000-0001-8809-9137"]},"institutions":[{"id":"https://openalex.org/I4210096033","display_name":"Kanion Pharmaceutical (China)","ror":"https://ror.org/00rn0n724","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210096033"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Wei Xiao","raw_affiliation_strings":["Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China. Electronic address: xw_kanion@163.com"],"raw_orcid":"https://orcid.org/0000-0001-8809-9137","affiliations":[{"raw_affiliation_string":"Jiangsu Kanion Pharmaceutical Co.,Ltd., Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City 222001, Jiangsu Province, China. Electronic address: xw_kanion@163.com","institution_ids":["https://openalex.org/I4210096033"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5113341378"],"corresponding_institution_ids":["https://openalex.org/I4210096033"],"apc_list":{"value":3250,"currency":"USD","value_usd":3250},"apc_paid":null,"fwci":0.8981,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.68091902,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":97},"biblio":{"volume":"136","issue":null,"first_page":"112383","last_page":"112383"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.5770999789237976,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.5770999789237976,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.25,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.12849999964237213,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bispecific-fusion-protein","display_name":"bispecific fusion protein","score":0.9980000257492065},{"id":"https://openalex.org/keywords/tnf-alpha-antagonism","display_name":"TNF-alpha antagonism","score":0.8730000257492065},{"id":"https://openalex.org/keywords/autoimmune-disease","display_name":"autoimmune disease","score":0.6660000085830688},{"id":"https://openalex.org/keywords/inflammatory-diseases","display_name":"inflammatory diseases","score":0.7799999713897705},{"id":"https://openalex.org/keywords/collagen-induced-arthritis","display_name":"collagen-induced arthritis","score":0.9919999837875366},{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.7950000166893005},{"id":"https://openalex.org/keywords/ixekizumab","display_name":"ixekizumab","score":0.9269999861717224},{"id":"https://openalex.org/keywords/etanercept","display_name":"etanercept","score":0.996999979019165},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.7590000033378601},{"id":"https://openalex.org/keywords/cynomolgus-monkeys","display_name":"Macaca fascicularis","score":0.8479999899864197}],"concepts":[{"id":"https://openalex.org/C123894998","wikidata":"https://www.wikidata.org/wiki/Q425158","display_name":"Fusion protein","level":4,"score":0.6252783536911011},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.5721940994262695},{"id":"https://openalex.org/C2779075594","wikidata":"https://www.wikidata.org/wiki/Q8084905","display_name":"Autoimmune disease","level":3,"score":0.5613181591033936},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5579464435577393},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5391415357589722},{"id":"https://openalex.org/C3020495827","wikidata":"https://www.wikidata.org/wiki/Q426141","display_name":"Bispecific antibody","level":4,"score":0.49181392788887024},{"id":"https://openalex.org/C47348012","wikidata":"https://www.wikidata.org/wiki/Q99486570","display_name":"Interleukin 17","level":3,"score":0.4794829785823822},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.42748236656188965},{"id":"https://openalex.org/C2780130043","wikidata":"https://www.wikidata.org/wiki/Q192360","display_name":"Autoimmunity","level":3,"score":0.42676037549972534},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.35426944494247437},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3226335346698761},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.2125033736228943},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20749828219413757},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.1555575430393219},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1315496265888214},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.118032306432724},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.11114946007728577},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07797491550445557},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.0745212733745575},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.06647849082946777}],"mesh":[{"descriptor_ui":"D000077271","descriptor_name":"Imiquimod","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001169","descriptor_name":"Arthritis, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001169","descriptor_name":"Arthritis, Experimental","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D001327","descriptor_name":"Autoimmune Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001327","descriptor_name":"Autoimmune Diseases","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008252","descriptor_name":"Macaca fascicularis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008811","descriptor_name":"Mice, Inbred DBA","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008822","descriptor_name":"Mice, Transgenic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019073","descriptor_name":"HT29 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020381","descriptor_name":"Interleukin-17","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054360","descriptor_name":"Chemokine CXCL1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D054360","descriptor_name":"Chemokine CXCL1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.intimp.2024.112383","doi":"https://doi.org/10.1016/j.intimp.2024.112383","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.intimp.2024.112383","pdf_url":null,"source":{"id":"https://openalex.org/S158377717","display_name":"International Immunopharmacology","issn_l":"1567-5769","issn":["1567-5769","1878-1705"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Immunopharmacology","raw_type":"journal-article"},{"id":"pmid:38843642","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38843642","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International immunopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W1553772156","https://openalex.org/W1564498610","https://openalex.org/W1737140009","https://openalex.org/W1980564318","https://openalex.org/W2028399234","https://openalex.org/W2060523664","https://openalex.org/W2065113992","https://openalex.org/W2097147259","https://openalex.org/W2120989550","https://openalex.org/W2121545373","https://openalex.org/W2128418183","https://openalex.org/W2329795532","https://openalex.org/W2803592648","https://openalex.org/W2806161046","https://openalex.org/W2884525830","https://openalex.org/W2894991604","https://openalex.org/W2904620045","https://openalex.org/W2916905588","https://openalex.org/W2953889774","https://openalex.org/W2972648237","https://openalex.org/W2984486845","https://openalex.org/W2999565226","https://openalex.org/W3010985447","https://openalex.org/W3014325962","https://openalex.org/W3034712716","https://openalex.org/W3041877993","https://openalex.org/W3134454558","https://openalex.org/W3173863744","https://openalex.org/W3209301640","https://openalex.org/W3217730252","https://openalex.org/W4284693043","https://openalex.org/W4313502673","https://openalex.org/W4381166201"],"related_works":["https://openalex.org/W2989729993","https://openalex.org/W7160940374","https://openalex.org/W1737140009","https://openalex.org/W7124238999","https://openalex.org/W3120941931","https://openalex.org/W2894991604","https://openalex.org/W4406821723","https://openalex.org/W4414977774","https://openalex.org/W3034712716","https://openalex.org/W4404272107"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-06-06T00:00:00"}